Oscillatorische Kontraktionen des Herzmuskels unter der Einwirkung von Adrenalin

Ohne Zusammenfassung     

Der Antagonismus zwischen Ca++ und Na+ am Papillarmuskel des Meerschweinchens in Abhängigkeit von der Reizfrequenz

Ohne Zusammenfassung     

Über Beziehungen Zwischen Antigen aus Säurefesten Bakterien und dem Serum Tuberkulöser Menschen

Ohne Zusammenfassung     

Der Einfluß der Hydrierung des Lactonringes von Ouabain und Digoxin auf die letale Wirkung am Meerschweinchen und auf die inotrope Wirkung am isolierten Papillarmuskel

Ohne Zusammenfassung     

Vaccination with BNT162b2 and ChAdOx1 nCoV-19 Induces Cross-Reactive Anti-RBD IgG against SARS-CoV-2 Variants including Omicron

SARS-CoV-2 variants of concern (VOCs) have caused a significant increase in infections worldwide. Despite high vaccination rates in industrialized countries, the fourth VOC, Omicron, has outpaced the Delta variant and is causing breakthrough infections in individuals with two booster vaccinations. While the magnitude of morbidity and lethality is lower in Omicron, the infection rate and global spread are rapid. Using a specific IgG multipanel-ELISA with the spike protein’s receptor-binding domain (RBD) from recombinant Alpha, Gamma, Delta, and Omicron variants, sera from health-care workers from the Medical University of Vienna were tested pre-pandemic and post-vaccination (BNT162b2; ChAdOx1 nCoV-19). The cohort was continuously monitored by SARS-CoV-2 testing and commercial nucleocapsid IgG ELISA. RBD IgG ELISA showed significantly lower reactivity against the Omicron-RBD compared to the Alpha variant in all individuals (p < 0.001). IgG levels were independent of sex, but were significantly higher in BNT162b2 recipients <45 years of age for Alpha, Gamma, and Delta (p < 0.001; p = 0.040; p = 0.004, respectively). Pre-pandemic cross-reactive anti-Omicron IgG was detected in 31 individuals and was increased 8.78-fold after vaccination, regardless of vaccine type. The low anti-RBD Omicron IgG level could explain the breakthrough infections and their presence could also contribute to a milder COVID-19 course by cross-reactivity and broadening the adaptive immunity.